(-)-alpha-phellandrene increases expression ISO RGD:1313544 6480464 alpha phellandrene results in increased expression of ACSS2 mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1313544 6480464 epigallocatechin gallate results in increased expression of ACSS2 mRNA CTD PMID:32512070 1,2-dichloroethane decreases expression ISO RGD:1618386 6480464 ethylene dichloride results in decreased expression of ACSS2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1618386 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1618386 6480464 1, 2-Dimethylhydrazine results in decreased expression of ACSS2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ACSS2 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO RGD:1618386 6480464 bisphenol A inhibits the reaction [Estradiol results in increased expression of ACSS2 mRNA] CTD PMID:28476547 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACSS2 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1618386 6480464 Estradiol results in increased expression of ACSS2 mRNA CTD PMID:28476547 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:1618386 6480464 Estradiol results in decreased expression of ACSS2 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1618386 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1313544 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313544 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACSS2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1618386 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618386 6480464 Tetrachlorodibenzodioxin affects the expression of ACSS2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1618386 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ACSS2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ACSS2 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1618386 6480464 Glucosamine results in increased expression of ACSS2 mRNA CTD PMID:17178593 3,4-dichloroaniline decreases expression EXP 6480464 3, 4-dichloroaniline results in decreased expression of ACSS2 mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1618386 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ACSS2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313544 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1618386 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ACSS2 mRNA CTD PMID:18648102 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ACSS2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ACSS2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1313544 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1313544 6480464 Acrylamide results in decreased expression of ACSS2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1313544 6480464 Aflatoxin B1 affects the expression of ACSS2 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1313544 6480464 Aflatoxin B1 results in decreased methylation of ACSS2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1313544 6480464 Aflatoxin B1 results in decreased expression of ACSS2 mRNA CTD PMID:21641981 more ... aldehydo-D-glucosamine increases expression ISO RGD:1618386 6480464 Glucosamine results in increased expression of ACSS2 mRNA CTD PMID:17178593 aldehydo-D-glucose increases expression ISO RGD:1313544 6480464 Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 aldrin increases expression ISO RGD:1618386 6480464 Aldrin results in increased expression of ACSS2 mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:1313544 6480464 Tretinoin results in increased expression of ACSS2 mRNA CTD PMID:33167477 all-trans-retinol decreases expression EXP 6480464 Vitamin A deficiency results in decreased expression of ACSS2 mRNA CTD PMID:12163651 alpha-phellandrene increases expression ISO RGD:1313544 6480464 alpha phellandrene results in increased expression of ACSS2 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:1313544 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA CTD PMID:32699268 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of ACSS2 mRNA CTD PMID:32084307 amiodarone increases expression ISO RGD:1618386 6480464 Amiodarone results in increased expression of ACSS2 mRNA CTD PMID:24535564 aristolochic acid A increases expression ISO RGD:1313544 6480464 aristolochic acid I results in increased expression of ACSS2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1618386 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:1618386 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA CTD PMID:32045263 arsenous acid decreases expression ISO RGD:1313544 6480464 Arsenic Trioxide results in decreased expression of ACSS2 mRNA CTD PMID:27829220 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ACSS2 mRNA CTD PMID:36841081 avobenzone increases expression ISO RGD:1313544 6480464 avobenzone results in increased expression of ACSS2 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:1618386 6480464 Benzo(a)pyrene results in decreased expression of ACSS2 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO RGD:1313544 6480464 Benzo(a)pyrene results in increased methylation of ACSS2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1313544 6480464 Benzo(a)pyrene results in decreased expression of ACSS2 mRNA CTD PMID:22178795 more ... benzo[a]pyrene increases expression ISO RGD:1618386 6480464 Benzo(a)pyrene results in increased expression of ACSS2 mRNA CTD PMID:19770486 , PMID:21964900 beta-D-glucosamine increases expression ISO RGD:1618386 6480464 Glucosamine results in increased expression of ACSS2 mRNA CTD PMID:17178593 bezafibrate affects expression EXP 6480464 Bezafibrate affects the expression of ACSS2 mRNA CTD PMID:17719200 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1618386 6480464 Diethylhexyl Phthalate results in increased expression of ACSS2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1313544 6480464 Diethylhexyl Phthalate results in decreased expression of ACSS2 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1618386 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 , PMID:28433925 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1313544 6480464 bisphenol A results in increased expression of ACSS2 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1313544 6480464 bisphenol A results in decreased methylation of ACSS2 gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ACSS2 mRNA CTD PMID:32145629 bisphenol A affects expression ISO RGD:1313544 6480464 bisphenol A affects the expression of ACSS2 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1618386 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 , PMID:28476547 bisphenol A increases expression ISO RGD:1618386 6480464 bisphenol A results in increased expression of ACSS2 mRNA CTD PMID:28476547 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACSS2 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:1313544 6480464 bisphenol B results in increased expression of ACSS2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1313544 6480464 bisphenol F results in increased expression of ACSS2 protein CTD PMID:34186270 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ACSS2 mRNA CTD PMID:32479839 caffeine affects phosphorylation ISO RGD:1313544 6480464 Caffeine affects the phosphorylation of ACSS2 protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:1618386 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carnosic acid increases expression ISO RGD:1618386 6480464 salvin results in increased expression of ACSS2 protein CTD PMID:35926579 CGP 52608 multiple interactions ISO RGD:1313544 6480464 CGP 52608 promotes the reaction [RORA protein binds to ACSS2 gene] CTD PMID:28238834 chloroethene increases expression ISO RGD:1618386 6480464 Vinyl Chloride results in increased expression of ACSS2 mRNA CTD PMID:18579281 chloroprene increases expression ISO RGD:1618386 6480464 Chloroprene results in increased expression of ACSS2 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:1313544 6480464 Cisplatin results in increased expression of ACSS2 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1313544 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ACSS2 mRNA, [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of ACSS2 mRNA CTD PMID:27392435 , PMID:30871063 clobetasol increases expression ISO RGD:1618386 6480464 Clobetasol results in increased expression of ACSS2 mRNA CTD PMID:27462272 copper atom multiple interactions ISO RGD:1313544 6480464 [Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1313544 6480464 [Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA CTD PMID:24690739 copper(II) chloride decreases expression ISO RGD:1313544 6480464 cupric chloride results in decreased expression of ACSS2 mRNA CTD PMID:34921933 copper(II) sulfate decreases expression ISO RGD:1313544 6480464 Copper Sulfate results in decreased expression of ACSS2 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1313544 6480464 coumarin results in increased phosphorylation of ACSS2 protein CTD PMID:35688186 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ACSS2 mRNA CTD PMID:21865292 cyclosporin A increases expression ISO RGD:1313544 6480464 Cyclosporine results in increased expression of ACSS2 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1313544 6480464 Cyclosporine results in decreased expression of ACSS2 mRNA CTD PMID:20106945 , PMID:23830897 cyclosporin A decreases expression ISO RGD:1618386 6480464 Cyclosporine results in decreased expression of ACSS2 mRNA CTD PMID:23830897 D-glucose increases expression ISO RGD:1313544 6480464 Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 DDT increases expression EXP 6480464 DDT results in increased expression of ACSS2 mRNA CTD PMID:29477483 dexamethasone increases expression ISO RGD:1313544 6480464 Dexamethasone results in increased expression of ACSS2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1313544 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1618386 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:1313544 6480464 Arsenic Trioxide results in decreased expression of ACSS2 mRNA CTD PMID:27829220 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ACSS2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1618386 6480464 Dibutyl Phthalate results in increased expression of ACSS2 mRNA CTD PMID:21266533 dimethylarsinous acid decreases expression ISO RGD:1313544 6480464 dimethylarsinous acid results in decreased expression of ACSS2 mRNA CTD PMID:23487506 dioxygen increases expression ISO RGD:1313544 6480464 Oxygen deficiency results in increased expression of ACSS2 mRNA CTD PMID:24236059 dioxygen multiple interactions ISO RGD:1618386 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS2 mRNA CTD PMID:30529165 dioxygen affects expression ISO RGD:1313544 6480464 Oxygen deficiency affects the expression of ACSS2 protein CTD PMID:26087400 disulfiram multiple interactions ISO RGD:1313544 6480464 [Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ACSS2 mRNA CTD PMID:21551480 , PMID:24172598 doxorubicin decreases expression ISO RGD:1313544 6480464 Doxorubicin results in decreased expression of ACSS2 mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of ACSS2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1618386 6480464 epoxiconazole results in decreased expression of ACSS2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1618386 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA CTD PMID:30517762 ethanol multiple interactions ISO RGD:1313544 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA CTD PMID:29432896 fenofibrate decreases expression ISO RGD:1313544 6480464 Fenofibrate results in decreased expression of ACSS2 mRNA CTD PMID:25572481 ferric oxide increases expression ISO RGD:1618386 6480464 ferric oxide analog results in increased expression of ACSS2 mRNA CTD PMID:25086211 folic acid multiple interactions ISO RGD:1618386 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA CTD PMID:22206623 Ganoderic acid A multiple interactions ISO RGD:1618386 6480464 [Dietary Fats co-treated with ganoderic acid A] affects the expression of ACSS2 mRNA CTD PMID:29852127 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACSS2 mRNA CTD PMID:22061828 , PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ACSS2 mRNA CTD PMID:24136188 glucose increases expression ISO RGD:1313544 6480464 Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 glycidyl methacrylate decreases expression ISO RGD:1313544 6480464 glycidyl methacrylate results in decreased expression of ACSS2 protein CTD PMID:36641056 indometacin multiple interactions ISO RGD:1313544 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA CTD PMID:28628672 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of ACSS2 mRNA CTD PMID:36868495 inulin multiple interactions ISO RGD:1618386 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:1313544 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1313544 6480464 Ivermectin results in decreased expression of ACSS2 protein CTD PMID:32959892 lipopolysaccharide decreases expression ISO RGD:1618386 6480464 Lipopolysaccharides results in decreased expression of ACSS2 mRNA CTD PMID:27339419 lovastatin multiple interactions ISO RGD:1618386 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of ACSS2 mRNA CTD PMID:29852127 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ACSS2 mRNA CTD PMID:28801915 methotrexate increases expression ISO RGD:1313544 6480464 Methotrexate results in increased expression of ACSS2 mRNA CTD PMID:17400583 methylparaben increases expression ISO RGD:1313544 6480464 methylparaben results in increased expression of ACSS2 mRNA CTD PMID:31745603 miconazole increases expression ISO RGD:1618386 6480464 Miconazole results in increased expression of ACSS2 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ACSS2 mRNA CTD PMID:28801915 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of ACSS2 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1313544 6480464 Nickel results in decreased expression of ACSS2 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1313544 6480464 nickel sulfate results in increased expression of ACSS2 mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:1313544 6480464 methyleugenol results in decreased expression of ACSS2 mRNA CTD PMID:32234424 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ACSS2 mRNA CTD PMID:19717638 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of ACSS2 mRNA CTD PMID:30316929 ozone multiple interactions ISO RGD:1313544 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1618386 6480464 Acetaminophen affects the expression of ACSS2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ACSS2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1313544 6480464 Acetaminophen results in decreased expression of ACSS2 mRNA CTD PMID:29067470 perfluorohexanesulfonic acid increases expression ISO RGD:1618386 6480464 perfluorohexanesulfonic acid results in increased expression of ACSS2 mRNA CTD PMID:21705711 perfluorononanoic acid decreases expression ISO RGD:1313544 6480464 perfluoro-n-nonanoic acid results in decreased expression of ACSS2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1313544 6480464 perfluorooctane sulfonic acid results in decreased expression of ACSS2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1618386 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1313544 6480464 perfluorooctanoic acid results in decreased expression of ACSS2 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1618386 6480464 perfluorooctanoic acid results in increased expression of ACSS2 mRNA CTD PMID:30657992 pirinixic acid decreases expression ISO RGD:1618386 6480464 pirinixic acid results in decreased expression of ACSS2 mRNA CTD PMID:18445702 potassium dichromate increases expression ISO RGD:1313544 6480464 Potassium Dichromate results in increased expression of ACSS2 protein CTD PMID:23718831 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1618386 6480464 Pregnenolone Carbonitrile results in decreased expression of ACSS2 mRNA CTD PMID:28903501 ritonavir affects expression EXP 6480464 Ritonavir affects the expression of ACSS2 mRNA CTD PMID:17719200 rotenone affects expression EXP 6480464 Rotenone affects the expression of ACSS2 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1618386 6480464 Rotenone results in increased expression of ACSS2 mRNA CTD PMID:32937126 rotenone increases expression ISO RGD:1313544 6480464 Rotenone results in increased expression of ACSS2 mRNA CTD PMID:29955902 silicon dioxide increases expression ISO RGD:1313544 6480464 Silicon Dioxide analog results in increased expression of ACSS2 mRNA CTD PMID:25895662 sodium acetate trihydrate increases expression ISO RGD:1313544 6480464 Sodium Acetate results in increased expression of ACSS2 mRNA CTD PMID:36156098 sodium arsenite increases expression ISO RGD:1313544 6480464 sodium arsenite results in increased expression of ACSS2 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:1618386 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA CTD PMID:32045263 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of ACSS2 mRNA CTD PMID:25993096 sunitinib increases expression ISO RGD:1313544 6480464 Sunitinib results in increased expression of ACSS2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1618386 6480464 Tamoxifen affects the expression of ACSS2 mRNA CTD PMID:20937368 temozolomide decreases expression ISO RGD:1313544 6480464 Temozolomide results in decreased expression of ACSS2 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1618386 6480464 Testosterone results in increased expression of ACSS2 mRNA CTD PMID:16579987 tetrachloromethane decreases expression ISO RGD:1618386 6480464 Carbon Tetrachloride results in decreased expression of ACSS2 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ACSS2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1618386 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA CTD PMID:30517762 tetracycline decreases expression ISO RGD:1618386 6480464 Tetracycline results in decreased expression of ACSS2 mRNA CTD PMID:24489787 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ACSS2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1618386 6480464 titanium dioxide results in decreased expression of ACSS2 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1618386 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA CTD PMID:29950665 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of ACSS2 mRNA CTD PMID:24136188 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ACSS2 mRNA CTD PMID:33387578 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ACSS2 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:1618386 6480464 triptolide results in decreased expression of ACSS2 mRNA CTD PMID:32835833 troglitazone decreases expression ISO RGD:1313544 6480464 troglitazone results in decreased expression of ACSS2 mRNA CTD PMID:25572481 trovafloxacin decreases expression ISO RGD:1618386 6480464 trovafloxacin results in decreased expression of ACSS2 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1313544 6480464 Urethane results in decreased expression of ACSS2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1313544 6480464 Valproic Acid results in decreased expression of ACSS2 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1313544 6480464 Valproic Acid affects the expression of ACSS2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1618386 6480464 Valproic Acid results in increased expression of ACSS2 mRNA CTD PMID:21427059 , PMID:24535564 valproic acid decreases methylation ISO RGD:1313544 6480464 Valproic Acid results in decreased methylation of ACSS2 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1618386 6480464 Valproic Acid affects the expression of ACSS2 mRNA CTD PMID:17292431 vancomycin increases expression ISO RGD:1618386 6480464 Vancomycin results in increased expression of ACSS2 mRNA CTD PMID:18930951 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of ACSS2 gene CTD PMID:31079544 Yessotoxin increases expression ISO RGD:1313544 6480464 yessotoxin analog results in increased expression of ACSS2 mRNA CTD PMID:30679557 zoledronic acid increases expression ISO RGD:1313544 6480464 zoledronic acid results in increased expression of ACSS2 mRNA CTD PMID:24714768